loadpatents
name:-0.064275979995728
name:-0.030829906463623
name:-0.012679100036621
SAH; Dinah Wen-Yee Patent Filings

SAH; Dinah Wen-Yee

Patent Applications and Registrations

Patent applications and USPTO patent grants for SAH; Dinah Wen-Yee.The latest application filed is for "aav variants with enhanced tropism".

Company Profile
20.35.70
  • SAH; Dinah Wen-Yee - Hopkinton MA
  • SAH; Dinah Wen-Yee - Cambridge MA
  • Sah; Dinah Wen-Yee - Boston MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Aav Variants With Enhanced Tropism
App 20220281922 - SAH; Dinah Wen-Yee ;   et al.
2022-09-08
Treatment of amyotrophic lateral sclerosis (ALS)
Grant 11,434,502 - Sah , et al. September 6, 2
2022-09-06
Compositions And Methods For Treating Huntington's Disease
App 20220275367 - Sah; Dinah Wen-Yee ;   et al.
2022-09-01
Treatment Of Amyotrophic Lateral Sclerosis (als)
App 20220211744 - SAH; Dinah Wen-Yee ;   et al.
2022-07-07
Treatment Of Amyotrophic Lateral Sclerosis And Disorders Associated With The Spinal Cord
App 20220168450 - SAH; Dinah Wen-Yee ;   et al.
2022-06-02
Modulatory Polynucleotides
App 20220162609 - Sah; Dinah Wen-Yee ;   et al.
2022-05-26
Frataxin Expression Constructs Having Engineered Promoters And Methods Of Use Thereof
App 20210395776 - PATZKE; Holger ;   et al.
2021-12-23
Compositions And Methods For Delivery Of Aav
App 20210371470 - Murlidharan; Giridhar ;   et al.
2021-12-02
Systems And Methods For Producing Gene Therapy Formulations
App 20210355454 - Cardinal; Jacob J. ;   et al.
2021-11-18
Assays For The Detection Of Aav Neutralizing Antibodies
App 20210285931 - Novobrantseva; Tatiana I. ;   et al.
2021-09-16
Aav Variants With Enhanced Tropism
App 20210277418 - Sah; Dinah Wen-Yee ;   et al.
2021-09-09
Treatment Of Amyotrophic Lateral Sclerosis And Disorders Associated With The Spinal Cord
App 20210254103 - Sah; Dinah Wen-Yee ;   et al.
2021-08-19
Compositions And Methods For Delivery Of Aav
App 20210230632 - Sah; Dinah Wen-Yee ;   et al.
2021-07-29
Compositions And Methods For Delivery Of Aav
App 20210163985 - Sah; Dinah Wen-Yee ;   et al.
2021-06-03
Compositions And Methods Of Treating Amyotrophic Lateral Sclerosis (als)
App 20210139915 - Sah; Dinah Wen-Yee ;   et al.
2021-05-13
Assays for the detection of AAV neutralizing antibodies
Grant 10,983,110 - Novobrantseva , et al. April 20, 2
2021-04-20
Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
Grant 10,920,227 - Sah , et al. February 16, 2
2021-02-16
Compositions And Methods Of Treating Huntington's Disease
App 20200377887 - Hou; Jinzhao ;   et al.
2020-12-03
Compositions and Methods for Inhibiting Expression of Transthyretin
App 20200283766 - Sah; Dinah Wen-Yee ;   et al.
2020-09-10
Modulatory Polynucleotides
App 20200270635 - Hou; Jinzhao ;   et al.
2020-08-27
Rescue Of Central And Peripheral Neurological Phenotype Of Friedreich's Ataxia By Intravenous Delivery
App 20200263199 - Sah; Dinah Wen-Yee ;   et al.
2020-08-20
Treatment Of Amyotrophic Lateral Sclerosis (als)
App 20200237799 - Sah; Dinah Wen-Yee ;   et al.
2020-07-30
Treatment Of Amyotrophic Lateral Sclerosis (als)
App 20200239912 - Sah; Dinah Wen-Yee ;   et al.
2020-07-30
siRNA Therapy for Transthyretin (TTR) Related Ocular Amyloidosis
App 20200199592 - Ando; Yukio ;   et al.
2020-06-25
Compositions And Methods Of Treating Huntington's Disease
App 20200155624 - Sah; Dinah Wen-Yee ;   et al.
2020-05-21
Compositions And Methods Of Treating Amyotrophic Lateral Sclerosis (als)
App 20200157547 - Sah; Dinah Wen-Yee ;   et al.
2020-05-21
Modulatory Polynucleotides
App 20200149045 - Sah; Dinah Wen-Yee ;   et al.
2020-05-14
Compositions And Methods Of Treating Amyotrophic Lateral Sclerosis (als)
App 20200123574 - Sah; Dinah Wen-Yee ;   et al.
2020-04-23
Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
Grant 10,597,660 - Sah , et al.
2020-03-24
Modulatory polynucleotides
Grant 10,584,337 - Sah , et al.
2020-03-10
Central Nervous System Targeting Polynucleotides
App 20190365793 - Stewart; Gregory Robert ;   et al.
2019-12-05
Compositions and Methods for Inhibiting Expression of Transthyretin
App 20190309293 - Sah; Dinah Wen-Yee ;   et al.
2019-10-10
Treatments for neurological disorders
Grant 10,328,125 - Rossomando , et al.
2019-06-25
Modulatory Polynucleotides
App 20190169616 - Sah; Dinah Wen-Yee ;   et al.
2019-06-06
Compositions And Methods For Treating Huntington's Disease
App 20190160091 - Sah; Dinah Wen-Yee ;   et al.
2019-05-30
Compositions and methods for inhibiting expression of transthyretin
Grant 10,240,152 - Sah , et al.
2019-03-26
Delivery Of Central Nervous System Targeting Polynucleotides
App 20190055578 - SAH; Dinah Wen-Yee ;   et al.
2019-02-21
Assays For The Detection Of Aav Neutralizing Antibodies
App 20180356394 - NOVOBRANTSEVA; Tatiana I. ;   et al.
2018-12-13
Compositions And Methods Of Treating Amyotrophic Lateral Sclerosis (als)
App 20180282732 - Sah; Dinah Wen-Yee ;   et al.
2018-10-04
siRNA Therapy for Transthyretin (TTR) Related Ocular Amyloidosis
App 20180171332 - Ando; Yukio ;   et al.
2018-06-21
Central Nervous System Targeting Polynucleotides
App 20180021364 - Stewart; Gregory Robert ;   et al.
2018-01-25
Compositions and Methods for Inhibiting Expression of Transthyretin
App 20170321213 - Sah; Dinah Wen-Yee ;   et al.
2017-11-09
siRNA Therapy for Transthyretin (TTR) Related Ocular Amyloidosis
App 20170096663 - Ando; Yukio ;   et al.
2017-04-06
Compositions and Methods for Inhibiting Expression of Transthyretin
App 20160264963 - Sah; Dinah Wen-Yee ;   et al.
2016-09-15
Lipid formulated compositions and methods for inhibiting expression of Eg5 and VEGF genes
Grant 9,339,513 - Gollob , et al. May 17, 2
2016-05-17
Lipid Formulated Compositions And Methods For Inhibiting Expression Of Transthyretin (TTR)
App 20160090593 - Sah; Dinah Wen-Yee
2016-03-31
siRNA Therapy for Transthyretin (TTR) Related Ocular Amyloidosis
App 20160076029 - Ando; Yukio ;   et al.
2016-03-17
Compositions And Methods For Inhibiting Expression Of GSK-3 Genes
App 20160024497 - Sah; Dinah Wen-Yee ;   et al.
2016-01-28
Compositions and methods for inhibiting expression of transthyretin
Grant 9,234,196 - Sah , et al. January 12, 2
2016-01-12
Compositions and Methods for Inhibiting Expression of Eg5 and VEGF Genes
App 20160000819 - Bumcrot; David ;   et al.
2016-01-07
Compositions and methods for inhibiting expression of an RNA from west nile virus
Grant 9,200,282 - Sah , et al. December 1, 2
2015-12-01
Lipid formulated compositions and methods for inhibiting expression of transthyretin (TTR)
Grant 9,101,643 - Sah August 11, 2
2015-08-11
Compositions and methods for inhibiting expression of GSK-3 genes
Grant 9,029,525 - Sah , et al. May 12, 2
2015-05-12
Compositions and methods for inhibiting expression of Eg5 and VEGF genes
Grant 9,006,197 - Bumcrot , et al. April 14, 2
2015-04-14
Lipid Formulated Compositions and Methods for Inhibiting Expression of Eg5 and VEGF Genes
App 20140336243 - Bumcrot; David ;   et al.
2014-11-13
Lipid formulated compositions and methods for inhibiting expression of Eg5 and VEGF genes
Grant 8,859,516 - Bumcrot , et al. October 14, 2
2014-10-14
Lipid Formulated Compositions and Methods for Inhibiting Expression of Eg5 And VEGF Genes
App 20140288154 - Bumcrot; David ;   et al.
2014-09-25
Compositions And Methods For Inhibiting Expression Of Transthyretin
App 20140194493 - Sah; Dinah Wen-Yee ;   et al.
2014-07-10
Compositions and methods for inhibiting expression of transthyretin
Grant 8,741,866 - Sah , et al. June 3, 2
2014-06-03
Compositions and Methods for Inhibiting Expression of an RNA from West Nile Virus
App 20140051747 - Sah; Dinah Wen-Yee ;   et al.
2014-02-20
Polymer-conjugated glycosylated neublastin
Grant 8,642,732 - Sah , et al. February 4, 2
2014-02-04
Compositions and methods for inhibiting expression of an RNA from West Nile virus
Grant 8,592,570 - Sah , et al. November 26, 2
2013-11-26
siRNA Therapy for Transthyretin (TTR) Related Ocular Amyloidosis
App 20130281510 - Ando; Yukio ;   et al.
2013-10-24
COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 AND VEGF GENES
App 20130023577 - Bumcrot; David ;   et al.
2013-01-24
Compositions And Methods For Inhibiting Expression Of GSK-3 Genes
App 20130012572 - Sah; Dinah Wen-Yee ;   et al.
2013-01-10
Polymer-conjugated Glycosylated Neublastin
App 20120316109 - Sah; Dinah Wen-Yee ;   et al.
2012-12-13
Lipid Formulated Compositions And Methods For Inhibiting Expression Of Transthyretin (TTR)
App 20120294905 - Sah; Dinah Wen-Yee
2012-11-22
Compositions and methods for inhibiting expression of huntingtin gene
Grant 8,314,075 - Sah , et al. November 20, 2
2012-11-20
Lipid Formulated Compositions And Methods For Inhibiting Expression Of Eg5 And VEGF Genes
App 20120282341 - Bumcrot; David ;   et al.
2012-11-08
Compositions And Methods For Inhibiting Expression Of Transthyretin
App 20120225927 - Sah; Dinah Wen-Yee ;   et al.
2012-09-06
Compositions and methods for inhibiting expression of transthyretin
Grant 8,168,775 - Sah , et al. May 1, 2
2012-05-01
Polymer conjugated glycosylated neublastin
Grant 8,163,875 - Sah , et al. April 24, 2
2012-04-24
Compositions And Methods For Inhibiting Expression Of Huntingtin Gene
App 20120095076 - Sah; Dinah Wen-Yee ;   et al.
2012-04-19
Polymer conjugates of mutated neublastin
Grant 8,119,114 - Sah , et al. February 21, 2
2012-02-21
Compositions and methods for inhibiting expression of Huntingtin gene
Grant 8,080,532 - Sah , et al. December 20, 2
2011-12-20
Compositions And Methods For Inhibiting Expression Of An RNA From West Nile Virus
App 20110251262 - Sah; Dinah Wen-Yee ;   et al.
2011-10-13
Compositions And Methods For Inhibiting Expression Of GSK-3 Genes
App 20110184046 - Sah; Dinah Wen-Yee ;   et al.
2011-07-28
Compositions and methods for inhibiting expression of Nav1.8 gene
Grant 7,902,168 - Sah , et al. March 8, 2
2011-03-08
Compositions And Methods For Inhibiting Expression Of Huntingtin Gene
App 20100298405 - Sah; Dinah Wen-Yee ;   et al.
2010-11-25
LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 AND VEGF GENES
App 20100267806 - Bumcrot; David ;   et al.
2010-10-21
Compositions and methods for inhibiting expression of Huntingtin gene
Grant 7,749,978 - Sah , et al. July 6, 2
2010-07-06
Compositions and Methods for Inhibiting Expression of Transthyretin
App 20100120893 - Sah; Dinah Wen-Yee ;   et al.
2010-05-13
Compositions and Methods for Inhibiting Expression of Eg5 and VEGF Genes
App 20100087508 - Bumcrot; David ;   et al.
2010-04-08
Treatments For Neurological Disorders
App 20090221495 - Rossomando; Anthony ;   et al.
2009-09-03
Anti-gfralpha3 Antibodies
App 20090202562 - Worley; Dane S. ;   et al.
2009-08-13
Polymer Conjugates Of Mutated Neublastin
App 20080306212 - Sah; Dinah Wen-Yee ;   et al.
2008-12-11
Polymer conjugates of mutated neublastin
Grant 7,442,370 - Sah , et al. October 28, 2
2008-10-28
Compositions And Methods For Inhibiting Expression Of Huntingtin Gene
App 20080221055 - Sah; Dinah Wen-Yee ;   et al.
2008-09-11
Compositions and methods for inhibiting expression of Huntingtin gene
Grant 7,320,965 - Sah , et al. January 22, 2
2008-01-22
Polymer-Conjugated Glycosylated Neublastin
App 20070238650 - Sah; Dinah Wen-Yee ;   et al.
2007-10-11
Compositions and methods for inhibiting expression of huntingtin gene
App 20070099860 - Sah; Dinah Wen-Yee ;   et al.
2007-05-03
Polymer conjugates of mutated neublastin
App 20050142098 - Sah, Dinah Wen-Yee ;   et al.
2005-06-30
Novel neurotrophic factors
App 20020055467 - Johansen, Teit E. ;   et al.
2002-05-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed